Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits [0.03%]
成人先天性心脏病的随访不同护理水平的成本分析：审视其对医疗费用、住院和急诊就诊的影响
Ruben Willems,Fouke Ombelet,Eva Goossens et al.
Ruben Willems et al.
Aim: To scrutinize the economic impact of different care levels, such as shared care, in the follow-up of adult congenital heart disease (ACHD) patients. ...
Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands [0.03%]
荷兰肠内分泌肿瘤患者的孤儿药Lu-Tk10与长效奥曲肽的经济评估研究
Marije E Hagendijk,Simon van der Schans,Cornelis Boersma et al.
Marije E Hagendijk et al.
Objectives: Multiple studies showed positive effects of Lutetium-Octreotate (LO) treatment in neuroendocrine tumours. LO has been used in the Netherlands since the 1980s and recently received the orphan status shortly aft...
Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data [0.03%]
德国协作骨科老年护理骨折患者的卫生经济学评估：使用健康和长期护理保险索赔数据的回顾性队列研究
Claudia Schulz,Gisela Büchele,Raphael S Peter et al.
Claudia Schulz et al.
Background: Evidence suggests benefits of orthogeriatric co-management (OGCM) for hip fracture patients. Yet, evidence on cost-effectiveness is limited and based on small datasets. The aim of our study was to conduct an e...
The causal impact of sugar taxes on soft drink sales: evidence from France and Hungary [0.03%]
含糖税对软饮料销售的因果影响：来自法国和匈牙利的证据
Christoph F Kurz,Adriana N König
Christoph F Kurz
Sugar-sweetened beverages (SSBs) are associated with increased body weight and obesity, which induce a wide array of health impairments such as diabetes or cardiovascular disorders. Excise taxes have been introduced to counteract SSB consum...
Has the development of cancer biomarkers to guide treatment improved health outcomes? [0.03%]
癌症生物标志物的发展能否指导治疗并改善健康结果？
Ana Beatriz D Avó Luís,Mikyung Kelly Seo
Ana Beatriz D Avó Luís
During the last decade, testing the patient's biomarker status prior to the administration of corresponding co-dependent therapies has been emerging in clinical practice. These biomarker-guided therapies have promoted the promise of more pe...
Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting [0.03%]
基于法国医疗体系的成本分析显示全外显子测序在癌症分子诊断中的使用率随时间下降
Arnaud Bayle,N Droin,B Besse et al.
Arnaud Bayle et al.
Objectives: Although high-throughput sequencing is revolutionising medicine, data on the actual cost of whole exome sequencing (WES) applications are needed. We aimed at assessing the cost of WES at a French cancer instit...
Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia [0.03%]
评估血友病患者中EQ-5D-5L和SF-6D的心理测量属性
Richard Huan Xu,Dong Dong,Nan Luo et al.
Richard Huan Xu et al.
Objective: The aim of this study was to evaluate the psychometric properties of the EQ-5D-5L and SF-6D, and to compare their performance among patients living with haemophilia in China. ...
Bayesian modeling of health state preferences: could borrowing strength from existing countries' valuations produce better estimates [0.03%]
基于现有国家估值的贝叶斯健康效用值模型：借力能否产生更好的估计值？
Samer A Kharroubi,Yara Beyh
Samer A Kharroubi
Background: Valuations of preference-based measure such as EQ-5D and/or SF6D have been conducted in different countries. There is potential to borrow strength from existing countries' valuations to generate better represe...
How Managed Entry Agreements can improve allocation in the public health system: a mechanism design approach [0.03%]
管理式准入协议如何能够改进公共医疗体系中的资源配置：机制设计的方法
Shuli Brammli-Greenberg,Ira Yaari,Elad Daniels et al.
Shuli Brammli-Greenberg et al.
The process of introducing a new health technology into a healthcare system is characterized by uncertainty and risk for those involved-pharmaceutical companies, payers, patients and the government. In view of the accelerated introduction o...
Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe [0.03%]
逆境之下地区间是否平等？欧洲COVID-19蔓延与动态的空间分析
Mounir Amdaoud,Giuseppe Arcuri,Nadine Levratto
Mounir Amdaoud
Often presented as a global pandemic spreading all over the world, COVID-19, however, hit not only countries but also regions differently. The objective of this paper is to focus on the spatial heterogeneity in the spread of the COVID-19 pa...